Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
OtherIUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels

George A. Gutman, K. George Chandy, Stephan Grissmer, Michel Lazdunski, David Mckinnon, Luis A. Pardo, Gail A. Robertson, Bernardo Rudy, Michael C. Sanguinetti, Walter Stühmer and Xiaoliang Wang
Pharmacological Reviews December 2005, 57 (4) 473-508; DOI: https://doi.org/10.1124/pr.57.4.10
George A. Gutman
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. George Chandy
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Grissmer
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Lazdunski
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Mckinnon
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis A. Pardo
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail A. Robertson
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernardo Rudy
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael C. Sanguinetti
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Stühmer
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoliang Wang
Department of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Department of Applied Physiology, Universitat Ulm, Ulm, Germany (S.G.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Valbonne, France (M.L.); Department of Neurobiology and Behavior, The State University of New York at Stony Brook, Health Sciences Center, Stony Brook, New York (D.M.); Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin (G.A.R.); Department of Physiology, Neuroscience, and Biochemistry, New York University School of Medicine, New York, New York (B.R.); Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah (M.C.S.); Max Planck Institute for Experimental Medicine, Abt. Molekulare Biologie Neuronaler Signale, Gottingen, Germany (L.A.P., W.S.); and Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China (X.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Introduction

Potassium-selective channels are the largest and most diverse group of ion channels, represented by some 70 known loci in the mammalian genome. The first cloned potassium channel gene was the Drosophila voltage-gated shaker channel, and this was rapidly followed by the identification of other voltage- and ligand-gated potassium channel genes in flies, mammals, and many other organisms. The voltage-gated Kv channels, in turn, form the largest family of some 40 genes among the group of human potassium channels, which also includes the Ca2+-activated (KCa), inward-rectifying (KIR), and two-pore (K2P) families described in the following articles of this compendium. Kv and KCa channels together constitute the six/seven-transmembrane group of potassium-selective channels, made up of subunits containing six or seven membrane-spanning domains, including the positively charged S4 segment, which confers on some of these channels their voltage sensitivity.

Table 1 lists the International Union of Pharmacology (IUPHAR1) names assigned to the members of the Kv family of channels, as well as the gene names established by the HUGO Gene Nomenclature Committee (HGNC). Two new sequences, Kv6.4 and Kv8.2, have been added to this list since the earlier edition of this compendium. Figures 1 and 2 show two phylogenetic tree reconstructions, one for the Kv1–9 families and the other for the Kv10–12 families, based on amino acid sequence alignments of the entire hydrophobic core of the proteins.

View this table:
  • View inline
  • View popup
TABLE 1

KV channel families Gene names shown are those assigned by the IUPHAR (Catterall et al., 2002) and HGNC (http://www.gene.ucl.ac.uk) in addition to some other commonly used names.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Phylogenetic tree for the Kv1–9 families. Amino acid sequence alignments of the human channel Kv proteins were created using CLUSTALW, and analysis by maximum parsimony using PAUP* resulted in unrooted trees comprising the Kv1-Kv6 and Kv8-Kv9 families that appeared in the previous edition of this compendium. Sequences of Kv7.1–7.5, Kv6.4, and Kv8.2 were added to the existing alignment, and these new sequences were incorporated into the existing tree topology by use of a combination of maximum parsimony and neighbor-joining analysis. Only the hydrophobic cores (S1–S6) were used for analysis. The IUPHAR and HGNC names are shown together with the genes' chromosomal localization and other commonly used names.

Kv channels form an exceedingly diverse group, much more so than one would predict simply based on the number of distinct genes that encode them. This diversity arises from several factors. 1) Heteromultimerization. Each Kv gene encodes a peptide subunit, four of which are required to form a functional channel. Kv channels may be homotetramers but may also be heterotetramers formed between different subunits within the same family (in the case of the Kv1, Kv7, and Kv10 families), and these diverse heterotetramers express properties that may be considerably different from those of any of the homotetramers. 2) “Modifier” subunits. Four of the Kv families (Kv5, 6, 8, and 9) encode subunits that act as modifiers. Although these do not produce functional channels on their own, they form heterotetramers with Kv2 family subunits, increasing the functional diversity within this family. 3) Accessory proteins. A variety of other peptides has also been shown to associate with Kv tetramers and modify their properties, including several β subunits (which associate with Kv1 and Kv2 channels), KCHIP1 (Kv4), calmodulin (Kv10), and minK (Kv11), as well as many others identified in the tables that follow the text of this article. 4) Alternate mRNA splicing. A number of Kv channel genes are known to contain intronless coding regions, including all of the Kv1 family genes (with the sole exception of Kv1.7) and Kv9.3. Although alternate splicing of noncoding exons may be important in regulating the expression of these channels, one gene can produce only a single kind of protein subunit. However, various members of the Kv3, 4, 6, 7, 9, 10, and 11 gene families have coding regions made up of several exons that are alternately spliced, providing yet another significant source of Kv channel functional diversity. 5) Post-translational modification. Many Kv channels can be post-translationally modified by phosphorylation (Jerng et al., 2004), ubiquitinylation (Henke et al., 2004), and palmitoylation (Gubitosi-Klug et al., 2005), which in turn modifies channel function.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Phylogenetic tree for the Kv10–12 families. This unrooted tree was created as described in Fig. 1 and appeared in the previous edition of this compendium. The IUPHAR and HGNC names are shown together with the genes' chromosomal localization and other commonly used names.

Our current understanding of the roles of this family of channels is catalogued in Tables 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, including recent developments in the pharmacology, regulation of expression, and disease associations of its various members (Misonou and Trimmer, 2004; Norton et al., 2004; Wua and Dworetzky, 2005).

View this table:
  • View inline
  • View popup
TABLE 2

KV1.1 channels

View this table:
  • View inline
  • View popup
TABLE 3

KV1.2 channels

View this table:
  • View inline
  • View popup
TABLE 4

KV1.3 channels

View this table:
  • View inline
  • View popup
TABLE 5

KV1.4 channels

View this table:
  • View inline
  • View popup
TABLE 6

KV1.5 channels

View this table:
  • View inline
  • View popup
TABLE 7

KV1.6 channels

View this table:
  • View inline
  • View popup
TABLE 8

KV1.7 channels

View this table:
  • View inline
  • View popup
TABLE 9

KV1.8 channels

View this table:
  • View inline
  • View popup
TABLE 10

KV2.1 channels

View this table:
  • View inline
  • View popup
TABLE 11

KV2.2 channels

View this table:
  • View inline
  • View popup
TABLE 12

KV3.1 channels

View this table:
  • View inline
  • View popup
TABLE 13

KV3.2 channels

View this table:
  • View inline
  • View popup
TABLE 14

KV3.3 channels

View this table:
  • View inline
  • View popup
TABLE 15

KV3.4 channels

View this table:
  • View inline
  • View popup
TABLE 16

KV4.1 channels

View this table:
  • View inline
  • View popup
TABLE 17

KV4.2 channels

View this table:
  • View inline
  • View popup
TABLE 18

KV4.3 channels

View this table:
  • View inline
  • View popup
TABLE 19

KV5.1 channels

View this table:
  • View inline
  • View popup
TABLE 20

KV6.1 channels

View this table:
  • View inline
  • View popup
TABLE 21

KV6.2 channels

View this table:
  • View inline
  • View popup
TABLE 22

KV6.3 channels

View this table:
  • View inline
  • View popup
TABLE 23

KV6.4 channels

View this table:
  • View inline
  • View popup
TABLE 24

KV7.1 channels

View this table:
  • View inline
  • View popup
TABLE 25

KV7.2 channels

View this table:
  • View inline
  • View popup
TABLE 26

KV7.3 channels

View this table:
  • View inline
  • View popup
TABLE 27

KV7.4 channels

View this table:
  • View inline
  • View popup
TABLE 28

KV7.5 channels

View this table:
  • View inline
  • View popup
TABLE 29

KV8.1 channels

View this table:
  • View inline
  • View popup
TABLE 30

KV8.2 channels

View this table:
  • View inline
  • View popup
TABLE 31

KV9.1 channels

View this table:
  • View inline
  • View popup
TABLE 32

KV9.2 channels

View this table:
  • View inline
  • View popup
TABLE 33

KV9.3 channels

View this table:
  • View inline
  • View popup
TABLE 34

KV10.1 channels

View this table:
  • View inline
  • View popup
TABLE 35

KV10.2 channels

View this table:
  • View inline
  • View popup
TABLE 36

KV11.1 channels

View this table:
  • View inline
  • View popup
TABLE 37

KV11.2 channels

View this table:
  • View inline
  • View popup
TABLE 38

KV11.3 channels

View this table:
  • View inline
  • View popup
TABLE 39

KV12.1 channels

View this table:
  • View inline
  • View popup
TABLE 40

KV12.2 channels

View this table:
  • View inline
  • View popup
TABLE 41

KV12.3 channels

Footnotes

  • ↵1 Abbreviations: IUPHAR, International Union of Pharmacology; HGNC, HUGO Gene Nomenclature Committee.

  • Article, publication date, and citation information can be found at http://pharmrev.aspetjournals.org.

  • doi:10.1124/pr.57.4.10.

  • The American Society for Pharmacology and Experimental Therapeutics

References

  1. ↵
    Catterall WA, Chandy KG, and Gutman GA, eds. (2002) The IUPHAR Compendium of Voltage-gated Ion Channels. IUPHAR Media, Leeds, UK.
  2. ↵
    Gubitosi-Klug RA, Mancuso DJ, and Gross RW (2005) The human Kv1.1 channel is palmitoylated, modulating voltage sensing: identification of a palmitoylation consensus sequence. Proc Natl Acad USA 102: 5964-5968.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Henke G, Maier G, Wallisch S, Boehmer C, and Lang F (2004) Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid inducible kinase SGK1. J Cell Physiol 199: 194-199.
    OpenUrlCrossRefPubMed
  4. ↵
    Jerng HH, Pfaffinger PJ, and Covarrubias M (2004) Molecular physiology and modulation of somatodendriticA-type potassium channels. Mol Cell Neurosci 27: 343-369.
    OpenUrlCrossRefPubMed
  5. ↵
    Misonou H and Trimmer JS (2004) Determinants of voltage-gated potassium channel surface expression and localization in mammalian neurons. Crit Rev Biochem Mol Biol 39: 125-145.
    OpenUrlCrossRefPubMed
  6. ↵
    Norton RS, Pennington MW, and Wulff H (2004) Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseases. Curr Med Chem 11: 3041-3052.
    OpenUrlPubMed
  7. ↵
    Wua YJ and Dworetzky SI (2005) Recent developments on KCNQ potassium channel openers. Curr Med Chem 12: 453-456.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Pharmacological Reviews: 57 (4)
Pharmacological Reviews
Vol. 57, Issue 4
1 Dec 2005
  • Table of Contents
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherIUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels

George A. Gutman, K. George Chandy, Stephan Grissmer, Michel Lazdunski, David Mckinnon, Luis A. Pardo, Gail A. Robertson, Bernardo Rudy, Michael C. Sanguinetti, Walter Stühmer and Xiaoliang Wang
Pharmacological Reviews December 1, 2005, 57 (4) 473-508; DOI: https://doi.org/10.1124/pr.57.4.10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherIUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels

George A. Gutman, K. George Chandy, Stephan Grissmer, Michel Lazdunski, David Mckinnon, Luis A. Pardo, Gail A. Robertson, Bernardo Rudy, Michael C. Sanguinetti, Walter Stühmer and Xiaoliang Wang
Pharmacological Reviews December 1, 2005, 57 (4) 473-508; DOI: https://doi.org/10.1124/pr.57.4.10
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • International Union of Pharmacology. LI. Nomenclature and Structure-Function Relationships of Cyclic Nucleotide-Regulated Channels
  • International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels
Show more IUPHAR Compendium of Voltage-Gated Ion Channels 2005

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics